---
figid: PMC7293394__nihms-1576117-f0002
figtitle: Antibody-mediated complement activation in pathology and protection
organisms:
- Human immunodeficiency virus 1
- Influenza A virus
- Human alphaherpesvirus 1
- Human betaherpesvirus 5
- Vaccinia virus
- Zika virus
- West Nile virus
- Human orthopneumovirus
- Mycobacterium tuberculosis
- Streptococcus pyogenes
- Borreliella burgdorferi
- Neisseria meningitidis
- Francisella tularensis
- Mus musculus
- Rattus norvegicus
- Plasmodium falciparum
- Plasmodium vivax
- Homo sapiens
- Lareunionomyces loeiensis
- NA
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC7293394
filename: nihms-1576117-f0002.jpg
figlink: pmc/articles/PMC7293394/figure/F1/
number: F1
caption: 'Figure reproduced with permission.(a) The complement cascade be initiated
  by three defined pathways, which commonly amplify through the C3 convertase, and
  terminate in target opsonization and/or membrane disruption. The classical pathway
  denotes activation of the complement cascade by the multi-functional C1q molecule,
  where C1q-mediated activation was classically defined by an initial recognition
  event by C1q of target-bound antibody. The Lectin pathway is initiated when specific
  polysaccharides are directly recognized by mannose-binding lectin (MBL), collectin-11
  (CL-11), or by members of the ficolin family (Fcn). The alternative pathway is generally
  characterized by low levels of continual activation that is typically tempered by
  host regulatory proteins to protect from self-inflicted tissue damage. (b) Gradually,
  the products of this low-level activation build up on surfaces lacking host complement
  regulatory proteins and reach a crescendo, resulting in (c) exponential amplification
  and cascade progression leading to (d, e) soluble inflammatory molecule generation,
  target opsonization, lytic insertion of the membrane attack complex (MAC), destruction,
  adherence and trafficking, adaptive immune education, and host clearance. Ag: antigen;
  Ab: antibody; C1q: complement component 1q; C1r/s: complement component 1q-associated
  serine proteases r and s; MBL: mannose binding lectin; MASP: MBL-associated serine
  proteases; Fcn: ficolins; CL-11: collectin-11; PAMP: pathogen-associated molecular
  pattern; FP: factor P (properdin); C3(H2O): hydrolyzed C3; FB: factor B, FD: factor
  D; RCA: regulators of complement activation; C4: complement component 4; C2: complement
  component 2; FI: factor I; CR1: complement receptor 1 (CD35); C3dg: complement fragment
  3dg; C3aR: C3a receptor; C5aR1 and 2: C5a receptor 1 and 2 (CD88 and C5L2, respectively);
  CRIg: CR of the immunoglobulin family; MAC: membrane attack complex (C5b-9); TCR:
  T-cell receptor; BCR: B-cell receptor.'
papertitle: Antibody-mediated complement activation in pathology and protection.
reftext: Benjamin S. Goldberg, et al. Immunol Cell Biol. ;98(4):305-317.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.891233
figid_alias: PMC7293394__F1
figtype: Figure
redirect_from: /figures/PMC7293394__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7293394__nihms-1576117-f0002.html
  '@type': Dataset
  description: 'Figure reproduced with permission.(a) The complement cascade be initiated
    by three defined pathways, which commonly amplify through the C3 convertase, and
    terminate in target opsonization and/or membrane disruption. The classical pathway
    denotes activation of the complement cascade by the multi-functional C1q molecule,
    where C1q-mediated activation was classically defined by an initial recognition
    event by C1q of target-bound antibody. The Lectin pathway is initiated when specific
    polysaccharides are directly recognized by mannose-binding lectin (MBL), collectin-11
    (CL-11), or by members of the ficolin family (Fcn). The alternative pathway is
    generally characterized by low levels of continual activation that is typically
    tempered by host regulatory proteins to protect from self-inflicted tissue damage.
    (b) Gradually, the products of this low-level activation build up on surfaces
    lacking host complement regulatory proteins and reach a crescendo, resulting in
    (c) exponential amplification and cascade progression leading to (d, e) soluble
    inflammatory molecule generation, target opsonization, lytic insertion of the
    membrane attack complex (MAC), destruction, adherence and trafficking, adaptive
    immune education, and host clearance. Ag: antigen; Ab: antibody; C1q: complement
    component 1q; C1r/s: complement component 1q-associated serine proteases r and
    s; MBL: mannose binding lectin; MASP: MBL-associated serine proteases; Fcn: ficolins;
    CL-11: collectin-11; PAMP: pathogen-associated molecular pattern; FP: factor P
    (properdin); C3(H2O): hydrolyzed C3; FB: factor B, FD: factor D; RCA: regulators
    of complement activation; C4: complement component 4; C2: complement component
    2; FI: factor I; CR1: complement receptor 1 (CD35); C3dg: complement fragment
    3dg; C3aR: C3a receptor; C5aR1 and 2: C5a receptor 1 and 2 (CD88 and C5L2, respectively);
    CRIg: CR of the immunoglobulin family; MAC: membrane attack complex (C5b-9); TCR:
    T-cell receptor; BCR: B-cell receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - App
  - H2-Ab1
  - C1qa
  - cir
  - Kcnj5
  - Cir1
  - Cish
  - Cs
  - Mbl2
  - fd
  - C2
  - C3
  - Cp
  - ap
  - Cr2
  - Igkv1-117
  - Cripto
  - Defa2
  - Cd46
  - Bcr
  - cri
  - Spsb3
  - Itgax
  - Itgam
  - Trav6-3
  - C3ar1
  - Hspa9
  - Ercc8
  - APP
  - SUCLA2
  - ADM
  - YME1L1
  - ERVK-3
  - C1QA
  - C1QB
  - KCNJ5
  - CIR1
  - VIM2P
  - CISH
  - MBL2
  - MBL3P
  - COLEC11
  - MASP1
  - SELE
  - SELL
  - SELP
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - CP
  - C3P1
  - CR1
  - CRIPTO
  - ERVK-2
  - CR2
  - CRIPTOP2
  - CD46
  - BCR
  - RN7SL263P
  - CRIPTOP4
  - CRIPTO3
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CS
  - C3AR1
  - ERCC8
  - CSH1
  - HSPA9
  - C5
  - C6
  - C7
  - C8A
  - C8B
  - C8G
  - C9
  - Th
  - Cr1l
  - ab
  - Appl
  - Cir
  - ci
  - mbl
  - fb
  - anon-16Fa
  - anon-16Fb
  - cp
  - conv
  - mtSSB
  - Cr-2
  - RhoGAP1A
  - cr-3
  - Tcr
  - cs
  - fi
  - yip7
  - mAcon1
  - FB
  - RCA
---
